Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1958 1
1982 1
1985 1
1986 1
1987 2
1988 1
1989 2
1990 1
1991 1
1992 2
1999 1
2002 1
2005 4
2006 2
2007 1
2008 3
2009 2
2010 4
2011 3
2012 7
2013 10
2014 6
2015 6
2016 13
2017 9
2018 8
2019 6
2020 6
2021 14
2022 10
2023 10
2024 8

Text availability

Article attribute

Article type

Publication date

Search Results

133 results

Results by year

Filters applied: . Clear all
Page 1
Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia.
Bhatt DL, Steg PG, Miller M, Brinton EA, Jacobson TA, Ketchum SB, Doyle RT Jr, Juliano RA, Jiao L, Granowitz C, Tardif JC, Ballantyne CM; REDUCE-IT Investigators. Bhatt DL, et al. N Engl J Med. 2019 Jan 3;380(1):11-22. doi: 10.1056/NEJMoa1812792. Epub 2018 Nov 10. N Engl J Med. 2019. PMID: 30415628 Clinical Trial.
Physiology and Physical Chemistry of Bile Acids.
di Gregorio MC, Cautela J, Galantini L. di Gregorio MC, et al. Int J Mol Sci. 2021 Feb 10;22(4):1780. doi: 10.3390/ijms22041780. Int J Mol Sci. 2021. PMID: 33579036 Free PMC article. Review.
Icosapent Ethyl Reduces Ischemic Events in Patients With a History of Previous Coronary Artery Bypass Grafting: REDUCE-IT CABG.
Verma S, Bhatt DL, Steg PG, Miller M, Brinton EA, Jacobson TA, Dhingra NK, Ketchum SB, Juliano RA, Jiao L, Doyle RT Jr, Granowitz C, Gibson CM, Pinto D, Giugliano RP, Budoff MJ, Mason RP, Tardif JC, Ballantyne CM; REDUCE-IT Investigators. Verma S, et al. Circulation. 2021 Dec 7;144(23):1845-1855. doi: 10.1161/CIRCULATIONAHA.121.056290. Epub 2021 Oct 28. Circulation. 2021. PMID: 34710343 Free article. Clinical Trial.
NEDA-3 achievement in early highly active relapsing remitting multiple sclerosis patients treated with Ocrelizumab or Natalizumab.
Signoriello E, Signori A, Lus G, Romano G, Marfia GA, Landi D, Napoli F, D' Amico E, Zanghí A, Di Filippo PS, Caliendo D, Carotenuto A, Spiezia AL, Fantozzi R, Centonze D, Lucchini M, Mirabella M, Cocco E, Frau J, Maniscalco GT, Di Battista ME, Foschi M, Surcinelli A, Bonavita S, Abbadessa G, Pasquali L, Di Gregorio M, Ferrò MT, Sormani MP, Schiavetti I; ON focus study group. Signoriello E, et al. Among authors: di gregorio m. Mult Scler Relat Disord. 2024 Jul;87:105594. doi: 10.1016/j.msard.2024.105594. Epub 2024 Apr 6. Mult Scler Relat Disord. 2024. PMID: 38718748 Free article.
Neonatal diagnosis of ACTA2-related disease: A case report and review of literature.
Lupo V, Di Gregorio MG, Mastrogiorgio G, Magliozzi M, Scapillati ME, Maglione V, Romanelli E, Alegiani C, Haass C, Novelli A. Lupo V, et al. Among authors: di gregorio mg. Am J Med Genet A. 2023 Apr;191(4):1111-1118. doi: 10.1002/ajmg.a.63118. Epub 2023 Jan 6. Am J Med Genet A. 2023. PMID: 36607831 Review.
Interaction Design Patterns for Augmented Reality Fitting Rooms.
Battistoni P, Di Gregorio M, Romano M, Sebillo M, Vitiello G, Brancaccio A. Battistoni P, et al. Among authors: di gregorio m. Sensors (Basel). 2022 Jan 27;22(3):982. doi: 10.3390/s22030982. Sensors (Basel). 2022. PMID: 35161727 Free PMC article.
133 results